Andrew Curtis is the Director at CURTIS Projects and Consulting, having held the role at Almac Group since 2025. Previously, they worked as a Senior Commissioning & Qualification Engineer at Pfizer from 2022 to 2023, focusing on the Tuas API facility expansion. Andrew's extensive experience includes roles at GSK as a Chemical Engineer in Continuous Processing and as a Process Engineer in R&D, where they supported GMP pilot scale production and quality management systems. They obtained a Master of Engineering (MEng) in Chemical Engineering from the University of Leeds, where they studied from 2010 to 2014.
This person is not in any teams
This person is not in any offices